Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals") and Formation Biotoday announced Formation Bio's acquisition of worldwide rights, excluding Greater China, to ...
Formation Bio and Lynk Pharmaceuticals today announced Formation Bio's acquisition of worldwide rights, excluding Greater China, to LNK01006, a next generation central nervous system (CNS)–penetrant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback